Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Restructuring Costs (2025 - 2026)

Global Innovative Platforms' (GIPL) quarterly Restructuring Costs came in at $288931.0 in Q2 2026, up 42.43% year-over-year from $202856.0 in Q2 2025, and up 12.84% quarter-over-quarter from $256062.0 in Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Global Innovative Platforms (GIPL) Restructuring Costs (2025 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed Restructuring Costs across 2 years of filings, most recently posting $288931.0 for Q2 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.39 Bn 40.19 Bn 779.09 Mn
2 Zoetis 30.46 Bn 28.78 Bn 1.05 Bn
3 Elanco Animal Health 11.57 Bn 11.04 Bn 798.00 Mn
4 Phibro Animal Health 1.48 Bn 1.40 Bn 134.40 Mn
5 Immucell 90.65 Mn 81.79 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 76.71 Mn 69.61 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 288,931.00
Mar 31, 2026 256,062.00
Jun 30, 2025 202,856.00
Mar 31, 2025 147,810.00